WaferGen Biosystems
Fremont
About WaferGen Biosystems
WaferGen Bio-systems, Inc. is an emerging genomic analysis company in the early stage of commercialization. The company offers the transformative SmartChip Real-Time PCR System’a next-generation Real-Time PCR System for profiling and validation of gene expression patterns (biomarkers) on a single platform. The SmartChip System provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling and single nucleotide polymorphism (SNP) genotyping.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $86.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2013)
- Ticker: nasdaq:WGBS
- Website: wafergen.com
- Phone: 510-651-4450
Industries & Categories
Biotechnology, Genetics, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/wafergen-biosystems-1073683 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.